NCT01850121View on ClinicalTrials.gov

Remicade in the Treatment of Patients With Active Ankylosing Spondylitis

CompletedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Ankylosing Spondylitis
Interventions
DRUG

Infliximab

5 mg/kg every 6 weeks during the first year and 3 mg/kg every 8 weeks during the second year. Concomitant treatment with methotrexate 7.5 mg/week.

Trial Locations (1)

S-413 45

Sahlgrenska University Hospital, Gothenburg

All Listed Sponsors
lead

Göteborg University

OTHER

NCT01850121 - Remicade in the Treatment of Patients With Active Ankylosing Spondylitis | Biotech Hunter | Biotech Hunter